304 related articles for article (PubMed ID: 35129409)
1. Investigational agents for the treatment of methicillin-resistant
Burgin DJ; Liu R; Hsieh RC; Heinzinger LR; Otto M
Expert Opin Investig Drugs; 2022 Mar; 31(3):263-279. PubMed ID: 35129409
[TBL] [Abstract][Full Text] [Related]
2. Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
Fowler VG; Das AF; Lipka-Diamond J; Ambler JE; Schuch R; Pomerantz R; Cassino C; Jáuregui-Peredo L; Moran GJ; Rupp ME; Lachiewicz AM; Kuti JL; Wise RA; Kaye KS; Zervos MJ; Nichols WG
Clin Infect Dis; 2024 Jun; 78(6):1473-1481. PubMed ID: 38297916
[TBL] [Abstract][Full Text] [Related]
3. National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020.
Chen CH; Wu PH; Lu MC; Ho MW; Hsueh PR;
Int J Antimicrob Agents; 2023 Apr; 61(4):106745. PubMed ID: 36758774
[TBL] [Abstract][Full Text] [Related]
4. Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future.
Bavaro DF; Belati A; Bussini L; Cento V; Diella L; Gatti M; Saracino A; Pea F; Viale P; Bartoletti M
Expert Opin Drug Saf; 2024 Jan; 23(1):9-36. PubMed ID: 38145925
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial prescribing for treatment of serious infections caused by Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in pediatrics: an expert review.
Avedissian SN; Rhodes NJ; Shaffer CL; Tran L; Bradley JS; Le J
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1107-1116. PubMed ID: 33554692
[No Abstract] [Full Text] [Related]
6. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
Holubar M; Meng L; Alegria W; Deresinski S
Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
8. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
Holubar M; Meng L; Deresinski S
Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
[TBL] [Abstract][Full Text] [Related]
9. The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection.
Gordon O; Dikeman DA; Ortines RV; Wang Y; Youn C; Mumtaz M; Orlando N; Zhang J; Patel AM; Gough E; Kaushik A; Nuermberger EL; Upton AM; Fotouhi N; Miller LS; Archer NK
Microbiol Spectr; 2022 Oct; 10(5):e0245121. PubMed ID: 36106881
[TBL] [Abstract][Full Text] [Related]
10. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
11. Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.
Burnett YJ; Echevarria K; Traugott KA
Ann Pharmacother; 2016 Dec; 50(12):1051-1059. PubMed ID: 27520326
[TBL] [Abstract][Full Text] [Related]
12. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia.
Haynes AS; Maples H; Parker S
J Pediatric Infect Dis Soc; 2023 May; 12(5):308-318. PubMed ID: 37144953
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.
Dhand A; Sakoulas G
Clin Ther; 2014 Oct; 36(10):1303-16. PubMed ID: 25444563
[TBL] [Abstract][Full Text] [Related]
14. Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections.
Canty E; Carnahan B; Curley T; Anususinha E; Hamdy RF; Ericson JE
Pediatr Infect Dis J; 2021 May; 40(5):429-433. PubMed ID: 33196562
[TBL] [Abstract][Full Text] [Related]
15. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2020.
Coombs GW; Daley DA; Yee NWT; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2022 Apr; 46():. PubMed ID: 35469556
[TBL] [Abstract][Full Text] [Related]
16. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.
Schuch R; Lee HM; Schneider BC; Sauve KL; Law C; Khan BK; Rotolo JA; Horiuchi Y; Couto DE; Raz A; Fischetti VA; Huang DB; Nowinski RC; Wittekind M
J Infect Dis; 2014 May; 209(9):1469-78. PubMed ID: 24286983
[TBL] [Abstract][Full Text] [Related]
18. The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant
Indiani C; Sauve K; Raz A; Abdelhady W; Xiong YQ; Cassino C; Bayer AS; Schuch R
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670427
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.
Gudiol C; Cuervo G; Shaw E; Pujol M; Carratalà J
Expert Opin Pharmacother; 2017 Dec; 18(18):1947-1963. PubMed ID: 29115883
[TBL] [Abstract][Full Text] [Related]
20. Important new therapies for methicillin-resistant
Bassetti M; Carnelutti A; Castaldo N; Peghin M
Expert Opin Pharmacother; 2019 Dec; 20(18):2317-2334. PubMed ID: 31622115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
